Clin2
NCT07061184Possibly a fitNot yet recruiting

Herbal medicine for diarrhea-predominant irritable bowel syndrome

Irritable Bowel Syndrome - DiarrhoeaTraditional Chinese Medicine (TCM)N of 1 Study DesignEfficacy and Safety

Part of Digestive system clinical trials.

This trial tests a Chinese herbal medicine called Fengliao Changweikang to see if it helps people with diarrhea-predominant irritable bowel syndrome (IBS-D). Each person tries the treatment and compares it to a placebo to find out if it works for them personally.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
50 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have mild to moderate IBS-D, with a symptom score between 75 and 300 points.
  • You are able to fill out questionnaires and give written consent.
  • If you take IBS medications, they must be at a stable dose for at least 30 days before starting, and you plan to keep the same dose, diet, and lifestyle during the trial.
  • Your blood counts, liver function, and kidney function tests are normal within the last 2 weeks.
  • You do not have other bowel diseases like inflammatory bowel disease, celiac disease, or cancer.
  • You are not pregnant or breastfeeding, and you do not have severe heart, kidney, or liver disease.
  • You do not have current alcohol or drug abuse problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06779214Not yet recruiting
Food compounds for irritable bowel syndrome with diarrhea

This study tests whether certain natural food ingredients can help ease digestive symptoms in adults with irritable bowel syndrome (IBS) that mainly causes diarrhea. If you have IBS-D, this trial could help you find a dietary approach to feeling better.

Beijing, Beijing Municipality
NCT07749092Recruiting
Kimchi powder for gut health in IBS

This study tests whether taking kimchi powder (a dried form of the fermented cabbage dish) can improve gut health and symptoms in people with diarrhea-predominant IBS. You'll avoid regular kimchi for about 2 months, then take the powder daily and track how you feel.

Yangsan
NCT06737666Recruiting· Phase 1
Tong-Xie-Yao-Fang for Diarrhea-Predominant IBS

This trial tests an herbal formula called Tong-Xie-Yao-Fang for people with diarrhea-predominant irritable bowel syndrome (IBS-D). It aims to see if the treatment helps symptoms and how it works. Healthy volunteers are also needed for comparison.

Beijing, Beijing Municipality
NCT06753890Not yet recruiting· Phase 3
Changkang granules for diarrhea-predominant irritable bowel syndrome

This trial tests a Chinese herbal medicine called Changkang granules to see if it can reduce belly pain and diarrhea in people with irritable bowel syndrome (IBS) where diarrhea is the main symptom. It may help if your IBS is linked to stress or emotions, which is called 'liver qi affecting the spleen' in traditional Chinese medicine.

Baoding
NCT07610434Not yet recruiting· Phase 3
Chinese herbal capsules for diarrhea-type irritable bowel syndrome

This study tests a traditional Chinese medicine capsule called Changji'an to see if it safely reduces diarrhea, pain, and bloating in people with diarrhea-type irritable bowel syndrome. These symptoms are thought to be caused by 'liver Qi invading the spleen.'

Beijing, Dongcheng District
NCT07721012Not yet recruiting· Phase 2
Traditional Chinese medicine pill for diarrhea-type irritable bowel syndrome

This study tests a traditional Chinese medicine pill called Huanghou Zhixie Diwan for people with irritable bowel syndrome with diarrhea (IBS-D). It aims to reduce belly pain and improve stool consistency, and may offer a new option for those who haven't found relief with standard treatments.

Beijing

Hear when a new Traditional Chinese Medicine (TCM) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.